Wang, H., Zhang, S., Wang, S., Lu, J., Wu, W., Weng, L., . . . Zhao, S. (2009). REV3L confers chemoresistance to cisplatin in human gliomas: The potential of its RNAi for synergistic therapy. Duke University Press.
Citación estilo ChicagoWang, Huibo, et al. REV3L Confers Chemoresistance to Cisplatin in Human Gliomas: The Potential of Its RNAi for Synergistic Therapy. Duke University Press, 2009.
Cita MLAWang, Huibo, et al. REV3L Confers Chemoresistance to Cisplatin in Human Gliomas: The Potential of Its RNAi for Synergistic Therapy. Duke University Press, 2009.
Precaución: Estas citas no son 100% exactas.